Tag
Tag: Antibodies
Abcam Makes Final Payment in the Acquisition of an US Antibody Biotech
AstraZeneca Misses the Mark in Late-Stage Asthma Trial
Scottish Shark Antibodies have caught Amgen’s Eye
The EU Approves New Treatment for a Rare Pediatric Cancer
Unexpected Side Effects: Are we Ready for the Rise of Immunotherapies?
How Biotech is Mastering Multiple Sclerosis: A Review
Next-Gen Cancer Antibody Technology from Germany enters the Clinic
Janssen Stops Phase II Trial for a Danish Blood Cancer Blockbuster
Get Ready for One of the Biggest New Drug Approvals of the Year
Roche lands FDA Approval for the Best Multiple Sclerosis Drug Yet
